carbamates has been researched along with Leukemia L 1210 in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (76.74) | 18.7374 |
| 1990's | 8 (18.60) | 18.2507 |
| 2000's | 2 (4.65) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DYER, E | 1 |
| REITZ, JM | 1 |
| FARRIS, RE | 1 |
| Duca, M | 1 |
| Arimondo, PB | 1 |
| Léonce, S | 1 |
| Pierré, A | 1 |
| Pfeiffer, B | 1 |
| Monneret, C | 1 |
| Dauzonne, D | 1 |
| Frühling, J | 1 |
| Penasse, W | 1 |
| Laurent, G | 1 |
| Brassionne, C | 1 |
| Hildebrand, J | 1 |
| Vanhaelen, M | 2 |
| Vanhaelen-Fastre, R | 2 |
| Deleers, M | 1 |
| Ruysschaert, JM | 1 |
| Tew, KD | 1 |
| Smulson, ME | 1 |
| Schein, PS | 1 |
| Brassinne, C | 1 |
| Mailliet, P | 1 |
| Segal-Bendirdjian, E | 1 |
| Kozelka, J | 1 |
| Barreau, M | 1 |
| Baudoin, B | 1 |
| Bissery, MC | 1 |
| Gontier, S | 1 |
| Laoui, A | 1 |
| Lavelle, F | 1 |
| Le Pecq, JB | 1 |
| Manfredini, S | 2 |
| Baraldi, PG | 2 |
| Bazzanini, R | 2 |
| Guarneri, M | 1 |
| Simoni, D | 2 |
| Balzarini, J | 2 |
| De Clercq, E | 2 |
| Hook, KE | 1 |
| Przybranowski, SA | 1 |
| Leopold, WR | 1 |
| Hegmans, A | 1 |
| Qu, Y | 1 |
| Kelland, LR | 1 |
| Roberts, JD | 1 |
| Farrell, N | 1 |
| Lin, TS | 1 |
| Fischer, PH | 1 |
| Shiau, GT | 1 |
| Prusoff, WH | 1 |
| De Brabander, M | 1 |
| Geuens, G | 1 |
| Van De Veire, R | 1 |
| Thoneé, F | 1 |
| Aerts, F | 1 |
| Desplenter, L | 1 |
| De Cree, J | 1 |
| Borgers, M | 1 |
| Hong, CI | 1 |
| Chheda, GB | 1 |
| Atassi, G | 2 |
| Tagnon, HJ | 2 |
| Schaus, C | 1 |
| Hoshi, A | 1 |
| Iigo, M | 1 |
| Yoshida, M | 1 |
| Kuretani, K | 1 |
| Suzuki, S | 1 |
| Mori, T | 1 |
| Ruckdeschel, JC | 1 |
| Modi, SP | 1 |
| el-Hamouly, W | 1 |
| Portuese, E | 1 |
| Archer, S | 1 |
| Sawada, S | 1 |
| Okajima, S | 1 |
| Aiyama, R | 1 |
| Nokata, K | 1 |
| Furuta, T | 1 |
| Yokokura, T | 1 |
| Sugino, E | 1 |
| Yamaguchi, K | 1 |
| Miyasaka, T | 1 |
| Temple, C | 2 |
| Rener, GA | 2 |
| Comber, RN | 2 |
| Waud, WR | 1 |
| Tabrizi, MA | 1 |
| Adams, N | 1 |
| Blake, C | 1 |
| Broadhurst, MJ | 1 |
| Bushnell, DJ | 1 |
| Hassall, CH | 1 |
| Hartmann, HR | 1 |
| Keech, E | 1 |
| Stratton, AR | 1 |
| Thomas, GJ | 1 |
| Steiman, R | 1 |
| Berlion, M | 2 |
| Seigle-Murandi, F | 1 |
| Bériel, H | 2 |
| Fillion, H | 2 |
| Riondel, J | 1 |
| Tinland, B | 1 |
| Bouaziz, Z | 1 |
| Nasr, M | 1 |
| Paull, KD | 1 |
| Narayanan, VL | 1 |
| Lacey, E | 1 |
| Watson, TR | 1 |
| Weaver, JD | 1 |
| Busch, NF | 1 |
| Stammer, CH | 1 |
| Nakamura, T | 1 |
| Tatsumi, K | 1 |
| Fukai, M | 1 |
| Sasada, M | 1 |
| Higuchi, T | 1 |
| Kojima, R | 1 |
| Driscoll, J | 1 |
| Mantel, N | 1 |
| Goldin, A | 2 |
| Fleming, WC | 1 |
| Lee, WW | 1 |
| Henry, DW | 1 |
| Ashton, WT | 1 |
| Kirk, LL | 1 |
| Baker, BR | 9 |
| Arakawa, M | 2 |
| Okada, N | 1 |
| Straus, MJ | 1 |
| Bessell, EM | 1 |
| Stock, JA | 1 |
| Westwood, JH | 1 |
| Lourens, GJ | 2 |
| Meyer, RB | 3 |
| Vermeulen, NM | 5 |
43 other studies available for carbamates and Leukemia L 1210
| Article | Year |
|---|---|
CARBAMATES DERIVED FROM AMINOPURINES.
Topics: 2-Aminopurine; Adenine; Animals; Antineoplastic Agents; Carbamates; Chemistry, Pharmaceutical; Leuke | 1963 |
Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Division; DNA; DNA Damage; Enzyme Inhibitors; Etopo | 2005 |
Intracellular penetration of liposomes containing a water insoluble antimitotic drug in L1210 cells.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Cell Nucleus; Cytoplasm; Fluorescence Po | 1980 |
Molecular pharmacology of nitrosoureas.
Topics: Alkylation; Animals; Antineoplastic Agents; Carbamates; Chromatin; Drug Interactions; HeLa Cells; Hu | 1981 |
High-performance liquid chromatography determination of Nocodazole in liposomes and L 1210 cells.
Topics: Animals; Benzimidazoles; Carbamates; Cell Line; Chromatography, High Pressure Liquid; Humans; Leukem | 1981 |
Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Survival; Cisplatin; In Vitro Techniques; Leukemia | 1995 |
Geiparvarin analogues. 4. Synthesis and cytostatic activity of geiparvarin analogues bearing a carbamate moiety or a furocoumarin fragment on the alkenyl side chain.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Cell Division; Cell Line; Cell Survival; Cou | 1994 |
Cellular transport of CI-980.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carbamates; Carrier Proteins; Cattle; CHO Cell | 1996 |
Novel approaches to polynuclear platinum pro-drugs. Selective release of cytotoxic platinum-spermidine species through hydrolytic cleavage of carbamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Catalysis; Chromatography, High Pressure Liquid; Female; | 2001 |
Antineoplastic agents. 1. Synthesis and antineoplastic activities of chloroethyl- and methylnitrosourea analogues of thymidine.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carbamates; Cell Division; Cells, Cultured; Chemi | 1978 |
The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivo.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Cell Survival; In Vitro Techniques; Leuk | 1977 |
Purinylhydantoins. Facile conversion of the naturally occurring N-(purin-6-ylcarbamoyl)-L-amino acids into 3-pruin-6-ylhydantoins and 3-cyclohexyl-1-(purin-6-ylcarbamoyl)hydantoins.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carbamates; Cell Line; Hydantoins; Leukemia L1210; Leuk | 1975 |
R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Ependymoma; Leukemia L1210; Leukemia, Ex | 1975 |
R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Cytarabine; Drug Synergism; Drug Therapy | 1975 |
Antitumor activity of carbamoyl derivatives of 5-fluorouracil by oral administration.
Topics: Administration, Oral; Animals; Carbamates; Fluorouracil; Leukemia L1210; Mice | 1975 |
Carbamoyl mycophenolic acid ethylester, an oral antitumor agent.
Topics: Administration, Oral; Animals; Carbamates; Carcinoma, Ehrlich Tumor; Leukemia L1210; Mice; Mycopheno | 1976 |
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung N | 1992 |
Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carbamates; Female; Irinotecan; Leukemia L | 1991 |
Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Structur | 1991 |
Geiparvarin analogues. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Coumarins; Furans; Humans; Leukemia L1210; M | 1991 |
Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: a novel class of anthracycline derivatives.
Topics: Animals; Antibiotics, Antineoplastic; Carbamates; Chemical Phenomena; Chemistry; Female; Leukemia L1 | 1990 |
Antibacterial, antifungal and antitumoral activities of 5-carbamoyloxy and 5-acyloxynaphthalene-1,8-carbolactones.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Carbamates; Cell Survival; | 1989 |
New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Survival; Indicators and Reagents; Leukemia L1210; | 1989 |
Correlation of the electronic parameters with the antitumoral activity of 5-carbamoyloxy and 5-acyloxy naphthalene-1,8-carbolactones.
Topics: Animals; Antineoplastic Agents; Carbamates; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry, | 1989 |
Computer-assisted structure--anticancer activity correlations of carbamates and thiocarbamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Computers; Leukemia L1210; Leukemia P388; Mice; Models, | 1985 |
Activity of benzimidazole carbamates against L1210 mouse leukaemia cells: correlation with in vitro tubulin polymerization assay.
Topics: Animals; Benzimidazoles; Carbamates; Chemical Phenomena; Chemistry; Leukemia L1210; Macromolecular S | 1985 |
Cycloserine carbamates.
Topics: Animals; Carbamates; Carcinoma; Cell Line; Chromatography, Thin Layer; Cycloserine; Leukemia L1210; | 1974 |
[Mode of action of carbazilquinone in leukemic cells (author's transl)].
Topics: Animals; Azirines; Carbamates; Carbon Radioisotopes; Cells, Cultured; Depression, Chemical; DNA, Neo | 1974 |
Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia.
Topics: Acetamides; Alkylation; Amines; Animals; Azirines; Carbamates; Hydroxylation; Leukemia L1210; Mice; | 1972 |
Synthesis of nucleoside 5'-carbamates.
Topics: Animals; Carbamates; Leukemia L1210; Methods; Mice; Ribonucleosides | 1973 |
Irreversible enzyme inhibitors. 198. Diaminodihydro-S-triazines and diaminopyrimidines bearing substituted (ureidomethyl)phenyl substituents as reversible inhibitors of dihydrofolate reductase.
Topics: Animals; Carbamates; Cell Survival; Cells, Cultured; Folic Acid Antagonists; Leukemia L1210; Methods | 1973 |
Effect of carbazilquinone on leukemic cell count in various tissues of mice bearing leukemia L-1210.
Topics: Animals; Antineoplastic Agents; Azirines; Blood Cells; Bone Marrow; Brain; Carbamates; Cell Count; K | 1974 |
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
Topics: Animals; Antineoplastic Agents; Azirines; Carbamates; Cyclophosphamide; Injections, Intraperitoneal; | 1972 |
Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
Topics: Animals; Antineoplastic Agents; Azirines; Carbamates; Injections, Intraperitoneal; Leukemia L1210; M | 1972 |
Acetylenic carbamates as potential antitumour agents.
Topics: Animals; Antineoplastic Agents; Carbamates; Leukemia L1210; Mice; Neoplasms, Experimental; Oxyphenbu | 1970 |
Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; F | 1969 |
Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; F | 1969 |
Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Culture Tech | 1969 |
Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; De | 1969 |
Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymet
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fl | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamido)phenoxymethyl]pyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists | 1969 |
Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fl | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenz amido) phenoxymethyl] pyrimidine, an active-site-directed irreverisible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists | 1969 |